Library - Page 13 - Scientific articles and publications about the drug Mexidol®.

Registered on ClinicalTrials

Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)

The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)

The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

The results of the study of the effectiveness and safety of the use of Mexidol in patients with chronic brain ischemia

Author:
E.I. Chukanova, A.S. Chukanova, H.I. Mamaeva

GBOU VPO “Russian National Research Medical University named after N.I. Pirogov ", Moscow

Oxidative stress and its correction for neurological diseases. Review of literature

Author:

A.I. Fedin

GBOU VPO “Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia

Place of publication:

Neurological practice

Issue No. 2 (5) February 2015

Aleksitimiy in patients with a heart attack of left -handed localization in the late recovery period

Authors:

Antonova N.A. , Kuznetsova E.B., Sholomov I.I.

GBOU VPO "Saratov State Medical University named after V.I. Razumovsky "of the Ministry of Health of Russia, the Department of Nervous Diseases

Place of publication:

Journal of Neurology and Psychiatry, 10, 2015

Neurometabolic therapy as a means of secondary prophylaxis of stroke

Author:
V.V. Kovalchuk

St. Petersburg GBUZ City Hospital No. 38 named after N.A. Semashko, St. Petersburg

Oxidative stress and its drug correction by Mexidol with traumatic brain injury

Author:
N.V. Govorov

State Budgetary Educational Institution of Higher Professional Education "Omsk State Medical Academy of the Ministry of Health", Omsk, Russia

The effectiveness of the drug "Mexidol" in patients with a combined traumatic brain injury

Authors:
I.B. Savitskaya, V.V. Nikonov, A.V. Chernov, A.Yu. Pavlenko, A.V. Beletsky

Kharkov Medical Academy of Postgraduate Education, Kharkov City Clinical Hospital of Emergency and Emergency Medical Assistance

Clinical experience in the use of Mexidol to correct astheno-vegetative disorders in patients who have suffered a mild traumatic brain injury

Author:
M.E. Sergienko

Road Clinical Hospital, Chelyabinsk

Features of the influence of Mexidol on the functional state of the central nervous system in patients who have suffered a stroke

Authors:
V.V. Kuznetsov, F.V. Yurchenko

Institute of Gerontology of AMNs of Ukraine, Kyiv

Clinical assessment of the drug Mexol in the treatment of severe traumatic brain injury at the stages of medical care

Author:
V.L. Dyushkevich

Voronezh State Medical Academy. N. N. Burdenko, Voronezh

Experience with the use of Mexidol in the treatment of concussion and in the late recovery period after severe traumatic brain injury in outpatient settings

Author:
A.V. IGNATOVA

Municipal Health Institution City Polyclinic No. 26, Novosibirsk

Randomized dual-blind, placebo-controlled study of the effectiveness and safety of Mexidol in the complex therapy of ischemic stroke in the acute period

Author:
V.I. CKBOPTSOBA, L.V. Stakhovskaya, Y.P. Narcissas, M.K. Bodykhov, I.V. Kichuk, Yu.V. Gudkova, T.A. Soldatenkova, T.T. Kondrashova, E.V. Kalinina, M.A. Novichkova, O.B. Kerbikov

Department of Fundamental and Clinical Neurology of the Russian State Medical University, Research Institute of Cytochemistry and Molecular Pharmacology, Moscow

Mexidol in the prevention of intracranial hypertension syndrome with the consequences of closed traumatic brain injury

Authors:
B.M. Doronin, A.Yu. Poyagin, O.B. Tyshkevich, V.B. Doronin

Novosibirsk State Medical University, Novosibirsk, 2006

The possibility of using Mexidol in neuropediatrics

Authors:
N.N. Zavadenko, N.Yu. Suvorinova, A.N. Zavadenko

FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)

Registered on ClinicalTrials

N.N. ZAVADENKO ¹ , N.Yu. SUVORINOVA ¹ , T.T. BATYSHEVA ² , O.V. BYKOVA ² , A.N. PLATONOVA ² , D.D. GAYNETDINOVA ³ , E.V. LEVITINA ⁴ , V.V. MASHIN ⁵ , I.N. VAKULA ⁶ , N.E. MAKSIMOVA ⁷

¹ FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia;
² GBUZ "Scientific and practical center of children's psychoneurology of the Department of Health of Moscow", Moscow, Russia;
³ FSBEI in Kazan State Medical University of the Ministry of Health of Russia, Kazan, Russia;
⁴ FSBEI in Tyumen State Medical University of the Ministry of Health of Russia, Tyumen, Russia;
⁵ FSBEI in Ulyanovsk State University, Ulyanovsk, Russia;
⁶ LLC "Center for Professional Therapy", Krasnodar, Russia;

⁷FSBEI in the Tver State Medical University, Tver, Russia

Place of publication:
a journal of neurology and psychiatry named after S.S. Korsakova, 2022, T.122, No. 4

Experience in the use of Mexidol® in children and adolescents with mental disorders

Authors:
Yu.Sh. Vasyanina

The use of Mexidol® in children's neurological practice

Authors:
G.R. Khamitova

« 1 … 11 12 13 14 »